<DOC>
	<DOCNO>NCT00511004</DOCNO>
	<brief_summary>This study conduct Kerala , India . It determine whether new treatment regimen albendazole diethylcarbamazine ( DEC ) lymphatic filariasis eliminate disease quickly standard regimen . Lymphatic filariasis cause infection small parasitic worm spread mosquito . The disease cause swell arm , leg , breast scrotum progress permanent swell leg arm call elephantiasis . The study see high frequent dose albendazole well clear filarial worm blood current treatment . Healthy people 18 55 year age good health infect filarial worm may eligible study . Participants undergo follow procedure : 3-day hospital stay Filariasis Chemotherapy Unit T.D . Medical College Hospital Kerala , India - Random assignment receive either : 400 mg albendazole DEC 300 mg give year 2 year ( standard treatment ) ; 800 mg albendazole DEC 300 mg give year 2 year ; 800 mg albendazole DEC 300 mg give twice year 2 year . - Urine pregnancy test woman childbearing age . - Ultrasound test look filarial worm . - Treatment dose . - Monitoring symptom 6-month 3-day hospital stay - Medical history , physical examination blood test . - Repeat ultrasound subject whose first ultrasound detect adult worm . - Treatment dose subject receive medicine every 6 month . - Urine pregnancy test woman childbearing age . 1-year 3-day hospital stay - Medical history , physical examination blood test . - Treatment dose . - Repeat ultrasound subject whose first ultrasound detect adult worm . - Urine pregnancy test woman childbearing age . 18-month 3-day hospital stay - Medical history , physical examination blood test . - Treatment dose subject receive medicine every 6 month . - Urine pregnancy test woman childbearing age . 24-month 3-day hospital stay - Medical history , physical examination blood test . - Treatment dose . - Repeat ultrasound subject whose first ultrasound detect adult worm . - Urine pregnancy test woman childbearing age .</brief_summary>
	<brief_title>Effect Albendazole Dose Treatment Lymphatic Filariasis</brief_title>
	<detailed_description>Albendazole diethylcarbamazine ( DEC ) currently use combination annual mass treatment lymphatic filariasis part world except Africa . Although drug donate , cost program high proven major impediment success program many country limit financial resource . Data albendazole treatment filarial infection one study compare single multi-dose DEC/albendazole lymphatic filariasis suggest increase dose and/or frequency albendazole dose may effective clearing microfilariae . In study , 75 volunteer microfilaremic Brugia malayi infection randomize receive standard annual therapy ( albendazole 400 mg + DEC 300 mg ) , annual therapy increase dose albendazole ( albendazole 800 mg + DEC 300 mg ) , semiannual therapy increase albendazole dose ( albendazole 800 mg + DEC 300 mg ) . Microfilarial level follow every 6 month 2 year determine whether high dose , and/or frequent regimen , effective .</detailed_description>
	<mesh_term>Filariasis</mesh_term>
	<mesh_term>Elephantiasis</mesh_term>
	<mesh_term>Elephantiasis , Filarial</mesh_term>
	<mesh_term>Diethylcarbamazine</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<criteria>INCLUSION CRITERIA : Inclusion Criteria Screening : Age 18 year 55 year inclusive Both gender Not pregnant breastfeed history If select , subject must willing spend 3 day Filariasis Chemotherapy Unit T.D . Medical College Hospital , Alleppey , Kerala , India If select , subject must willing undergo nighttime blood draw every 6 month Doppler ultrasound twice yearly 2 year If select , agree blood store future study Ability understand give inform consent Inclusion Criteria Treatment : Age 18 55 year inclusive Men nonpregnant nonbreast feed woman Microfilarial level great 50mf/mL Willingness spend 3 day Filariasis Chemotherapy Unit T.D . Medical College Hospital , Alleppey , Kerala , India every 6 month 2 year Willingness undergo nighttime blood draw every 6 month 2 year Ability understand give inform consent Hemaglobin ( Hgb ) level inclusion great 9 g/dL Creatinine ( Cr ) less equal 1.2 mg/dL Alanine aminotransferase ( ALT ) less 30 U/L Willingness blood store future study EXCLUSION CRITERIA : Exclusion Criteria Screening : Age le 18 year great 55 year Pregnant breast feed history Exclusion Criteria Treatment : Nonvolunteers Age less 18 year great 55 year Pregnant breast feed Hgb level less equal 9 g/dL Cr great 1.3 mg/dL ALT great 30 U/L Alcohol consumption 2 beer alcoholcontaining drinks/day within week drug administration Temperature great 37.5 degree Celsius Serious medical illness History benzimidazole allergy History DEC allergy Use albendazole DEC within past 6 month Unwillingness comply require study visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Brugia Malayi</keyword>
	<keyword>Lymphatic Filariasis</keyword>
	<keyword>Albendazole</keyword>
	<keyword>Diethylcarbamazine</keyword>
</DOC>